Catheter Precision (VTAK) Consolidated Net Income (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Consolidated Net Income data on file, last reported at -$1.7 million in Q1 2026.

• On a quarterly basis, Consolidated Net Income rose 58.22% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$10.7 million, a 28.35% increase from a year earlier, with the FY2025 full-year figure at -$15.4 million, down 14.12% from the prior year.
• Consolidated Net Income for Q1 2026 stood at -$1.7 million, down from -$370000.0 in the prior quarter.
• Over the last five years, Consolidated Net Income for VTAK reached as high as -$370000.0 in Q4 2025 and fell as low as -$66.4 million in Q1 2023.
• Historically, Consolidated Net Income has averaged -$7.4 million across 5 years, with a median of -$4.0 million in 2025.
• Across the five-year window, Consolidated Net Income slumped 1439.43% in 2022 and jumped 95.97% in 2024, its largest moves.
• Year by year, Consolidated Net Income stood at -$8.2 million in 2022, then surged by 91.8% to -$669000.0 in 2023, then plunged by 271.75% to -$2.5 million in 2024, then surged by 85.12% to -$370000.0 in 2025, then slumped by 356.76% to -$1.7 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were -$1.7 million in Q1 2026, -$370000.0 in Q4 2025, and -$2.2 million in Q3 2025.